Italian HCV eradication screening protocol and genotypes characterization (2022–2023) in Ferrara’s province: a real-world study
The prognosis associated factors of chronic hepatitis C patients and a case report of resistance-associated substitutions to sofosbuvir-velpatavir treatment
Epistatic interactions promote resistance against direct-acting antivirals targeting the HCV NS3 protein
Signatures of VH1-69-derived hepatitis C virus neutralizing antibody precursors defined by binding to envelope glycoproteins